Kazia Therapeutics (KZIA) Selling, General & Administrative (2009 - 2016)

Kazia Therapeutics (KZIA) Selling, General & Administrative (2009 - 2016) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Oculis Holding AG 66,140.12 Bn 66,139.83 Bn - -10.08 Mn
2 Nanobiotix 1,912.79 Bn 1,912.73 Bn - -
3 Akari Therapeutics 1,022.34 Bn 1,022.34 Bn - 2.17 Mn
4 BeOne Medicines 472.60 Bn 467.81 Bn 1.35 Bn 555.10 Mn
5 Vertex Pharmaceuticals 122.34 Bn 115.09 Bn 2.59 Bn 493.70 Mn
6 Regeneron Pharmaceuticals 70.14 Bn 61.39 Bn 3.31 Bn 647.70 Mn
7 Belite Bio 62.79 Bn 62.79 Bn - 17.02 Mn
8 Argenx Se 56.19 Bn 51.00 Bn 1.41 Bn 1.13 Bn
9 Alnylam Pharmaceuticals 37.50 Bn 34.49 Bn 959.66 Mn 322.55 Mn
10 Kazia Therapeutics 19.19 Bn 19.19 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2016 -2.98 Mn
Jun 30, 2010 175,039.19
Dec 31, 2009 256,324.49